National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze‐Bagno A Ripoli study

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Diabetes, obesity and metabolism

• Publication date

  2008-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1463-1326.2007.00724.xPMID 17419722
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• How well does the metabolic syndrome defined by five definitions predict incident diabetes and incident coronary heart disease in a Chinese population?

  2007cited by this paper
• IDF and ATP‐III definitions of metabolic syndrome in the prediction of all‐cause mortality in type 2 diabetic patients

  2007cited by this paper
• Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.

  2005cited by this paper
• The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.

  2005cited by this paper
• The metabolic syndrome: requiescat in pace.

  2005cited by this paper
• Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

  2005cited by this paper
• Prediction of Type 2 Diabetes Mellitus With Alternative Definitions of the Metabolic Syndrome: The Insulin Resistance Atherosclerosis Study

  2005cited by this paper
• The metabolic syndrome: time for a critical appraisal

  2005cited by this paper
• The metabolic syndrome--a new worldwide definition.

  2005cited by this paper
• The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions

  2005cited by this paper
• Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence.

  2005cited by this paper
• The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study.

  2003cited by this paper
• Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance

  2003cited by this paper
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.

  2002cited by this paper
• Cardiovascular morbidity and mortality associated with the metabolic syndrome.

  2001cited by this paper
• Obesity: preventing and managing the global epidemic. Report of a WHO consultation.

  2000cited by this paper
• Obesity : Preventing and managing the global epidemic

  2000cited by this paper
• 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension endorsed by the Lebanese Hypertension League

  1999cited by this paper
• 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization.

  1999cited by this paper
• A critique of the world health organization-international society of hypertension guidelines for the management of hypertension

  1999cited by this paper

• Gender Difference in the Association Between Serum Uric Acid Level and Metabolic Syndrome and Components: A Cross-Sectional Analysis Among Chinese Young Adults

  2020cites this paper
• METABOLIC SYNDROME AMONG SHIFT WORKERS IN MINIA MILLS, EGYPT

  2020cites this paper
• Efficacy and Safety of Pioglitazone Monotherapy in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomised Controlled Trials

  2019cites this paper
• Pharmacotherapy of Children and Adolescents with Type 2 Diabetes Mellitus.

  2019cites this paper
• Efficacy and safety of thiazolidinediones in diabetes patients with renal impairment: a systematic review and meta-analysis

  2017cites this paper
• Diabetes management in older people: a focus on cardiovascular risk reduction

  2017cites this paper
• CHAPTER 13 RISK FACTORS FOR TYPE 2 DIABETES

  2017cites this paper
• Association of Nutritional Status and Serum Leptin in Offsprings of Diabetic Parents of Karachi, Pakistan

  2016cites this paper
• Treating Diabetes in Patients with Heart Failure: Moving from Risk to Benefit

  2016cites this paper
• Drug therapies for HIV-related metabolic disorders

  2016cites this paper
• Cardiovascular effects of anti-diabetes drugs

  2016cites this paper
• Regardless of central obesity, metabolic syndrome is a significant predictor of type 2 diabetes in Japanese Americans

  2015cites this paper
• Type 2 diabetes mellitus: limitations of conventional therapies and intervention with nucleic acid-based therapeutics.

  2015cites this paper
• Debate: Testosterone Therapy Reduces Cardiovascular Risk in Men with Diabetes. Against the Motion

  2015cites this paper
• Pharmacokinetics and clinical evaluation of the alogliptin plus pioglitazone combination for type 2 diabetes

  2015cites this paper
• The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk.

  2014cites this paper
• The Role of PPARγ in Stroke

  2014cites this paper
• Improvement of Insulin Sensitivity by a Novel Drug Candidate, BGP-15, in Different Animal Studies

  2014cites this paper
• One-hundred days monitoring patients submitted to hematopoietic stem cell transplantation: Events of metabolic syndrome

  2014cites this paper
• Mind the mortality gap: the importance of metabolic function in mental illnesses

  2013cites this paper
• Effect of Pioglitazone Versus Metformin on Cardiovascular Risk Markers in Type 2 Diabetes

  2013cites this paper
• Effects on Lipid Profile of Dipeptidyl Peptidase 4 Inhibitors, Pioglitazone, Acarbose, and Sulfonylureas: Meta-analysis of Placebo-Controlled Trials

  2012cites this paper
• Utilization of a Metabolic Syndrome Index in Evaluating the Life in Balance Lifestyle Intervention for Prevention of Type 2 Diabetes among Urban American Indians and Alaska Natives

  2012cites this paper
• The Metabolic Syndrome and Risk of Chronic Kidney Disease: Pathophysiology and Intervention Strategies

  2012cites this paper
• Pioglitazone limits myocardial infarct size, activates Akt, and upregulates cPLA2 and COX-2 in a PPAR-γ-independent manner

  2011cites this paper
• Peroxisome proliferator-activated receptor-γ and the endothelium: implications in cardiovascular disease

  2011cites this paper
• Management of cardiovascular risk factors with pioglitazone combination therapies in type 2 diabetes: an observational cohort study

  2011cites this paper
• Thiazolidinediones and Risk of Heart Failure in Patients with or at High Risk of Type 2 Diabetes Mellitus

  2011cites this paper
• 3-Aryl-2-{4-[4-(2,4-dioxothiazolidin-5-ylmethyl)phenoxy]-phenyl}-acrylic acid alkyl ester: synthesis and antihyperglycemic evaluation

  2011cites this paper
• Association between HTR2C polymorphisms and metabolic syndrome in patients with schizophrenia treated with atypical antipsychotics.

  2011cites this paper
• Association of weight gain and metabolic syndrome in patients taking clozapine: an 8-year cohort study.

  2011cites this paper
• Effect of pioglitazone on systemic inflammation is independent of metabolic control and cardiac autonomic function in patients with type 2 diabetes

  2010cites this paper
• Pioglitazone in the Treatment of Type 2 Diabetes: Safety and Efficacy Review

  2010cites this paper
• The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA.

  2010cites this paper
• Update on the Safety of Thiazolidinediones

  2010cites this paper
• Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.

  2010cites this paper
• Clinical evaluation of combined therapy for type 2 diabetes

  2010cites this paper
• Diabetes and Cardiovascular Disease: Is intensive glucose control beneficial or deadly? Lessons from ACCORD, ADVANCE, VADT, UKPDS, PROactive, and NICE-SUGAR

  2010cites this paper
• Is the evidence from clinical trials for cardiovascular risk or harm for glitazones convincing?

  2009cites this paper
• Glomerular hyperfiltration and metabolic syndrome: results from the FIrenze-BAgno A Ripoli (FIBAR) Study

  2009influential citation
• Impact of metabolic syndrome compared to impaired fasting glucose on the development of type 2 diabetes in a general Japanese population: the Hisayama Study

  2009cites this paper
• Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseases.

  2009cites this paper
• Metabolic syndrome and the development of vascular disease and type 2 diabetes in high-risk patients

  2009cites this paper
• Comparison of metabolic syndrome with glucose measurement for prediction of type 2 diabetes: The Isfahan Diabetes Prevention Study

  2009cites this paper
• Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.

  2009cites this paper
• Impact of Metabolic Syndrome Compared With Impaired Fasting Glucose on the Development of Type 2 Diabetes in a General Japanese Population

  2009cites this paper
• Diabetes and Metabolic Syndrome in Middle-aged and Elderly Adults : a Population-based Study in Jiangsu Province, China

  2008cites this paper
• Metabolic syndrome and risk of incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition-Potsdam Study

  2008cites this paper
• Diabetes and Metabolic Syndrome in Middle-aged and Elderly Adults : a Population-based Study in Jiangsu Province , China

  2008cites this paper
• Diet or exercise: what is more effective in preventing or reducing metabolic alterations?

  2008cites this paper
• Metabolic syndrome and incidence of type 2 diabetes in patients with manifest vascular disease

  2008cites this paper
• Current literature in diabetes

  2008cites this paper
• Metabolic Syndrome and Incident Diabetes

  2008cites this paper
• Multifactorial intervention in metabolic syndrome targeting at prevention of chronic kidney disease--ready for prime time?

  2007cites this paper
• The Metabolic Syndrome and Risk of Cardiovascular Disease and Diabetes: Experiences with the New Diagnostic Criteria from the International Diabetes Federation

  2007cites this paper
• Cardiovascular risk in the metabolic syndrome: Fact or fiction?

  2007cites this paper
• Changes in the Prevalence of Metabolic Syndrome in a Rural Area of Korea Defined by Two Criteria, Revised National Cholesterol Education Program and International Diabetes Federation

  2007cites this paper
• Preventing cardiovascular and renal complications in the management of hypertension and metabolic syndrome

  2007cites this paper